Trade 349

SELL CRM

0.408601052 shares at $171.08 on 2026-05-12

Reasoning

CRM at $171.41 has breached the $170 invalidation level from thesis #238. Stock is 8% below $186.70 cost basis. REVERSAL JUSTIFICATION: (a) May 11 playbook recommended BUY invest_dollar=$200 to reach 7% target ahead of May 27 earnings. (b) NEW EVIDENCE: April CPI print at 3.8% (highest since May 2023) is a material macro shift. Core CPI at 2.8% with 0.4% monthly beat expectations. Rate cut expectations have evaporated (BofA forecasts no cuts until H2 2027); rate hike odds now 30%. This fundamentally invalidates the pre-earnings constructive macro assumption. Citigroup lowered price target today. Growth SaaS names face asymmetric downside risk from multiple compression in a higher-for-longer rates regime. Trimming 50% reduces binary event exposure while preserving upside optionality if CRM stabilizes above $170 and shows strength into earnings. Rule 27 macro constraint applies: $500/day cap on new deployment during rate-path fragility. Selling into uncertainty is prudent risk management.

Thesis

Salesforce approaching May 26-27 earnings binary event. CRM is now trading below the $170 invalidation level on hot CPI data driving broad tech selloff and Citigroup lowering its price target. The original thesis of SaaS momentum and Agentforce traction remains but the macro environment has shifted materially against growth/tech names with CPI at 3.8% and rate cut expectations evaporating. The position is underwater significantly. Risk-reward ahead of earnings is now asymmetric to the downside given macro headwinds and deteriorating price action. (long, low confidence)

Cited evidence

News

Macro